drugset / Trial / NCT02288338
CKD-391 DDI : Atorvastatin and Ezetimibe in Healthy Volunteers
RandomizedCrossoverOpen-labelTreatment
Summary
A randomized open-label, multiple dose, three-treatment, three-period, six-sequence, crossover study to investigate the pharmacokinetic drug interaction between Atorvastatin and Ezetimibe after oral administration in healthy volunteers
Timeline
- Start
- 2014-11
- Primary completion
- 2015-02
- Completion
- 2015-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 40 mg | Oral |
| Subject | Ezetimibe | Unknown | 10 mg | Oral |
Indications
No indication recorded.